BBIO
BridgeBio Pharma Inc
Price:  
55.03 
USD
Volume:  
1,183,849.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BridgeBio EV/EBITDA

-202.3%
Upside

As of 2025-10-17, the EV/EBITDA ratio of BridgeBio Pharma Inc (BBIO) is -19.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BridgeBio's latest enterprise value is 12,434.65 mil USD. BridgeBio's TTM EBITDA according to its financial statements is -622.03 mil USD. Dividing these 2 quantities gives us the above BridgeBio EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.4x - 14.4x 13.3x
Forward P/E multiples 13.6x - 15.7x 15.2x
Fair Price (54.40) - (56.87) (56.30)
Upside -198.8% - -203.3% -202.3%
55.03 USD
Stock Price
(56.30) USD
Fair Price

BridgeBio EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-10-16 -19.99
2025-10-15 -20.48
2025-10-14 -20.44
2025-10-13 -20.28
2025-10-10 -20.13
2025-10-09 -19.92
2025-10-08 -20.07
2025-10-07 -19.74
2025-10-06 -19.86
2025-10-03 -19.32
2025-10-02 -19.45
2025-10-01 -19.51
2025-09-30 -19.04
2025-09-29 -19.05
2025-09-26 -18.46
2025-09-25 -18.14
2025-09-24 -18.64
2025-09-23 -18.91
2025-09-22 -18.92
2025-09-19 -19.17
2025-09-18 -19.47
2025-09-17 -18.81
2025-09-16 -18.90
2025-09-15 -18.90
2025-09-12 -18.82
2025-09-11 -19.24
2025-09-10 -19.35
2025-09-09 -19.52
2025-09-08 -19.76
2025-09-05 -19.48
2025-09-04 -19.01
2025-09-03 -19.01
2025-09-02 -18.44
2025-08-29 -18.99
2025-08-28 -19.23
2025-08-27 -18.32
2025-08-26 -18.10
2025-08-25 -17.61
2025-08-22 -18.16
2025-08-21 -18.52
2025-08-20 -18.10
2025-08-19 -18.11
2025-08-18 -18.14
2025-08-15 -18.85
2025-08-14 -18.81
2025-08-13 -18.56
2025-08-12 -18.16
2025-08-11 -17.90
2025-08-08 -17.39
2025-08-07 -17.20